VANCOUVER, British Columbia--(BUSINESS WIRE)--March 29, 2006--MIV Therapeutics, Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems, has announced the availability of an updated Investor Fact Sheet that outlines the Company's proprietary and novel technologies, and its research programs to develop improved coatings for drug-eluting vascular stents and other implantable medical devices.
